FDA Inspection 1205966 — Deborah P. Saunders
The FDA completed an inspection of Deborah P. Saunders on March 28, 2023 in Sudbury. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 28, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Sudbury (Canada)
Additional Details
Clinical Investigator (CI)